Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Pharmather Holdings Ltd PHRRF


Primary Symbol: C.PHRM

PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The... see more

Bullboard (CSE:PHRM)

View:
Post by 19LDS84on Dec 24, 2020 12:28pm

Great buy

What a lovely Christmas gift to get to buy at this discount. Cheers
Post by cool888on Dec 21, 2020 8:55am

$PHRM - Update

PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics
Post by cool888on Dec 20, 2020 9:27pm

Psychedelic - Spend time with CNN's Lisa Lang @10pm today

  'This Is Life' explores psychedelic healing This is Life with Lisa Ling Lisa Ling explores the medical uses of psychedelics and examines how for some the hallucinogenic toolbox ...more  
Post by cool888on Dec 20, 2020 8:37pm

$PHRM - Corporate Presentation December 2020

https://www.pharmather.com/uploads/1/2/5/8/125844350/deck_-_phrm_-_1020201.pdf
Post by cool888on Dec 20, 2020 8:34pm

$PHRM - Technical Chart ($$$$$)

https://www.barchart.com/stocks/quotes/PHRM.CN/technical-chart
Comment by JethroBlackon Dec 13, 2020 7:21pm

RE:THIS LITTLE MUSHROOM BULL IS READY....

Do we have any instutional exposure? I see FSD pharm and Cohen own large chunk. Looks like next leg up this week.
Post by rpthethirdon Dec 07, 2020 8:58am

Wow! Great for the sector

Looks like cybin just brought big pharma into the psychedlic industry.. check out the release https://www.businesswire.com/news/home/20201207005298/en/CYBIN-Signs-Definitive-Agreement-to-Acquire ...more  
Post by ExoticPlantson Nov 26, 2020 3:23am

Save 15-20% @ Herb Approach + Black Friday Sale

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #454545} span.s1 {text-decoration: underline ; color: #e4af09} Take advantage of massive Black Friday sales and save an ...more  
Post by Paymenow99on Nov 18, 2020 11:01am

New Deal

Phrm&Rvv, just hooked up technology's for the next shrooms medical treatment, so much potential here,,alot of people suffering here,,GLTA,longs
Post by Meticulouson Oct 27, 2020 8:10am

Great release this morning. Stock is going to 50

They are on to something big. Orphan drug status jumps the line with the fda. They are sharper than Mmed and the others. This stock is going to 40 or 50 by Christmas.  https://www.globenewswire ...more  
Post by PsilocybinAlphaon Oct 20, 2020 7:21am

Pharmather Files for FDA Orphan Drug Designation

Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease Pharmather has filed an application with the FDA for Orphan Drug Designation, which is reserved for rare ...more  
Post by Meticulouson Oct 09, 2020 12:03am

What price will this open at?

My guess is around 35 cents. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities